HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
RCT
BV100 (rifabutin for infusion) showed dose-proportional pharmacokinetics and safety in healthy volunteers
A New IV Drug Targets the Hardest Hospital Infections to Treat
This Phase 1 randomized controlled trial evaluated the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healt…
A reformulated intravenous version of the antibiotic rifabutin appears safe in healthy volunteers and may give doctors a new tool for treati…
Apr 13, 2026
Infectious Disease
RCT
Phase 1 trial shows linear pharmacokinetics and good tolerability for HRS-8427 in healthy Chinese adults
Can a new antibiotic candidate be safely tested in people? Early results look promising
A phase 1 randomized controlled trial in 79 healthy Chinese adults evaluated the pharmacokinetics and safety of intravenous HRS-8427.
A new antibiotic candidate shows promising early safety results in healthy adults, with predictable dosing and no serious side effects repor…
Apr 4, 2026